Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydrocortisone vs Pasireotide in Pancreatic Resection
NCT02775227Phase 4Active, not recruiting
- Sponsor
- Helsinki University Hospital
- Start
- May 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydrocortisone in pancreatic fistula (POPF), sponsored by Helsinki University Hospital. Started May 2016; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT02775227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775227.